Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Kitakaze

Showing results (51-60 of 433) with videos related to

Pageof 44
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 28, 2017
Reply to 'Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure'Miki Imazu, Hiroyuki Takahama, Masafumi Kitakaze
Circulation Research|October 30, 2010
Endoplasmic reticulum stress as a therapeutic target in cardiovascular diseaseTetsuo Minamino, Issei Komuro, Masafumi Kitakaze
Current Drug Metabolism|December 20, 2003
The role of estrogen and estrogen-related drugs in cardiovascular diseasesHisakazu Ogita, Koichi Node, Masafumi Kitakaze
Advances in Therapy|April 24, 2014
Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trialsAtsuhiro Sakamoto, Toshimitsu Hamasaki, Masafumi Kitakaze
Cardiovascular Research|October 27, 2015
Targeting lysosomal Ca2+ to reduce reperfusion injuryOsamu Tsukamoto, Hiroshi Asanuma, Masafumi Kitakaze
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2003
[Adenosine and ischemic heart disease]Tetsuo Minamino, Masatsugu Hori, Masafumi Kitakaze
American Journal of Physiology. Heart and Circulatory Physiology|August 23, 2011
Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measuresShoji Sanada, Issei Komuro, Masafumi Kitakaze
Circulation Journal : Official Journal of the Japanese Circulation Society|November 28, 2006
Tiotropium, a novel muscarinic M3 receptor antagonist, improved symptoms of chronic obstructive pulmonary disease complicated by chronic heart failureMahoto Kato, Kazuo Komamura, Masafumi Kitakaze
Circulation. Heart Failure|October 8, 2009
Should we use outpatient dobutamine or milrinone?Mahoto Kato, Shoji Sanada, Masafumi Kitakaze
Cardiovascular Research|August 18, 2009
Functional alterations of cardiac proteasomes under physiological and pathological conditionsOsamu Tsukamoto, Tetsuo Minamino, Masafumi Kitakaze
Pageof 44

Showing results (51-60 of 433) with videos related to

Sort By:
Pageof 44
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 28, 2017
Reply to 'Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure'Miki Imazu, Hiroyuki Takahama, Masafumi Kitakaze
Circulation Research|October 30, 2010
Endoplasmic reticulum stress as a therapeutic target in cardiovascular diseaseTetsuo Minamino, Issei Komuro, Masafumi Kitakaze
Current Drug Metabolism|December 20, 2003
The role of estrogen and estrogen-related drugs in cardiovascular diseasesHisakazu Ogita, Koichi Node, Masafumi Kitakaze
Advances in Therapy|April 24, 2014
Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trialsAtsuhiro Sakamoto, Toshimitsu Hamasaki, Masafumi Kitakaze
Cardiovascular Research|October 27, 2015
Targeting lysosomal Ca2+ to reduce reperfusion injuryOsamu Tsukamoto, Hiroshi Asanuma, Masafumi Kitakaze
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2003
[Adenosine and ischemic heart disease]Tetsuo Minamino, Masatsugu Hori, Masafumi Kitakaze
American Journal of Physiology. Heart and Circulatory Physiology|August 23, 2011
Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measuresShoji Sanada, Issei Komuro, Masafumi Kitakaze
Circulation Journal : Official Journal of the Japanese Circulation Society|November 28, 2006
Tiotropium, a novel muscarinic M3 receptor antagonist, improved symptoms of chronic obstructive pulmonary disease complicated by chronic heart failureMahoto Kato, Kazuo Komamura, Masafumi Kitakaze
Circulation. Heart Failure|October 8, 2009
Should we use outpatient dobutamine or milrinone?Mahoto Kato, Shoji Sanada, Masafumi Kitakaze
Cardiovascular Research|August 18, 2009
Functional alterations of cardiac proteasomes under physiological and pathological conditionsOsamu Tsukamoto, Tetsuo Minamino, Masafumi Kitakaze
Pageof 44